OPTIBUMIN

WIPO WIPO 2019

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark OPTIBUMIN was filed as Word mark on 01/09/2019 at the World Intellectual Property Organization.

Trademark Details Last update: January 1, 2021

Trademark form Word mark
File reference 1457458
Countries European Community United Kingdom Japan South Korea Singapore
Base trademark US No. 88036684, July 13, 2018
Application date January 9, 2019
Expiration date January 9, 2029

Trademark owner

2718 Industrial Drive
Junction City KS 66441
US

Trademark representatives

10801 Mastin Blvd., Suite 1000 Overland Park KS 66210 US

goods and services

01 Recombinant albumin in the nature of excipients for use in the manufacture of pharmaceutical preparations, cellular therapies, gene therapies and vaccines; recombinant albumin for use as a reagent for scientific and research use, namely, biomedical research and development
05 Recombinant albumin for biological therapeutic purposes; recombinant albumin for use as a reagent for medical use, namely, in-vitro fertilization, tissue sealant, tissue and cell cryopreservation, and blood detoxification

Trademark history

Date Document number Area Entry
November 19, 2020 2020/48 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
May 21, 2020 2020/21 Gaz JP Rejection
March 2, 2020 2020/10 Gaz KR Rejection
September 6, 2019 2019/37 Gaz SG Rejection
August 27, 2019 2019/35 Gaz EM Rejection
June 5, 2019 2019/23 Gaz GB Rejection
January 9, 2019 2019/10 Gaz US Registration

ID: 141457458